As of April 1, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) trades at $13.68, marking a 0.51% decline in the latest trading session. This analysis explores key technical levels, recent market context for the biopharmaceutical stock, and potential near-term price scenarios based on current trading patterns. No recent earnings data is available for TNXP as of this writing, so price action is currently driven primarily by sector sentiment and technical flows rather than quarterly fundamental pe
TNXP Stock Analysis: Tonix Pharmaceuticals Holding Corp dips 0.51 pct to 13.68
TNXP - Stock Analysis
4063 Comments
1844 Likes
1
Dmaya
Legendary User
2 hours ago
Comprehensive US stock historical volatility analysis and expected range projections for risk management. We provide volatility metrics that help you set appropriate stop-loss levels and position sizes.
👍 169
Reply
2
Telisha
Active Reader
5 hours ago
Real-time US stock institutional ownership tracking and fund flow analysis to understand who owns and is buying specific stocks in the market. We monitor 13F filings and institutional buying patterns because large investors often have superior information and research capabilities. We provide ownership data, fund flow analysis, and institutional positioning for comprehensive coverage. Follow institutional money with our comprehensive ownership tracking and analysis tools for smarter investment decisions.
👍 264
Reply
3
Isabelo
Engaged Reader
1 day ago
I understood nothing but I’m thinking hard.
👍 126
Reply
4
Avyukta
Consistent User
1 day ago
This hurts a little to read now.
👍 163
Reply
5
Kyann
Elite Member
2 days ago
I didn’t even know this existed until now.
👍 276
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.